A stage-specific functional role of the leucine zipper transcription factor c-Maf in lung Th2 cell differentiation

被引:11
作者
Hausding, M
Ho, IC
Lehr, HA
Weigmann, B
Lux, C
Schipp, M
Galle, PR
Finotto, S
机构
[1] Johannes Gutenberg Univ Mainz, Med Clin 1, Lab Cellular & Mol Lung Immunol, D-55131 Mainz, Germany
[2] Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[3] Johannes Gutenberg Univ Mainz, Dept Pathol, D-6500 Mainz, Germany
[4] Med Clin 1, Dept Immunol, Mainz, Germany
关键词
allergy; Th1/Th2; cells; transcription factors; transgenic/knockout; lung;
D O I
10.1002/eji.200425121
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor c-Maf controls IL-4 gene expression in CD4(+) Tcells, and its expression is up-regulated in human asthmatic airways after allergen challenge. In the present study, we addressed the role of c-Maf in asthma by studying transgenic, (Tg) mice overexpressing c-Maf in CD4(+) T cells under the control of the CD2 promoter. As shown, lung CD4(+) T cells of c-maf-Tg mice produced more IL-5 at the early stage (day 2) of culture in the presence of IL-4 than wild-type control cells. Consistently, c-maf-Tg mice spontaneously showed increased IL-5 expression and eosinophils in the bronchial alveolar lavage fluid (BALF) and activated IL-5 signal transduction via Raf-1 and Ras in lung eosinophils. Finally, IL-13 was suppressed in the BALF of c-maf-Tg mice and in supernatants of Tg lung CD4(+) T cells cultured in the presence of IL-2. Consistently, retroviral overexpression of c-Maf suppressed IL-13 production in developing lung Th2 cells. In summary, c-Maf induces IL-5 production in lung CD4(+) Tcells at an early stage, but along with IL-2 suppresses IL-13 production in differentiating lung Th2 cells, thereby explaining the finding that overexpression of c-Maf does not cause airway hyperresponsiveness, a hallmark feature of asthma.
引用
收藏
页码:3401 / 3412
页数:12
相关论文
共 38 条
[1]   Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity [J].
Akbari, O ;
Stock, P ;
Meyer, E ;
Kronenberg, M ;
Sidobre, S ;
Nakayama, T ;
Taniguchi, M ;
Grusby, MJ ;
DeKruyff, RH ;
Umetsu, DT .
NATURE MEDICINE, 2003, 9 (05) :582-588
[2]   A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation [J].
Das, J ;
Chen, CH ;
Yang, LY ;
Cohn, L ;
Ray, P ;
Ray, A .
NATURE IMMUNOLOGY, 2001, 2 (01) :45-50
[3]  
Demoulin JB, 1998, CYTOKINES CELL MOL T, V4, P243
[4]   New insights into the pathogenesis of asthma [J].
Elias, JA ;
Lee, CG ;
Zheng, T ;
Ma, B ;
Homer, RJ ;
Zhu, Z .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :291-297
[5]  
Erpenbeck VJ, 2003, CHEST, V123, p370S
[6]   Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet [J].
Finotto, S ;
Neurath, MF ;
Glickman, JN ;
Qin, SX ;
Lehr, HA ;
Green, FHY ;
Ackerman, K ;
Haley, K ;
Gatte, PR ;
Szabo, SJ ;
Drazen, JM ;
De Sanctis, GT ;
Glimcher, LH .
SCIENCE, 2002, 295 (5553) :336-338
[7]   Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression [J].
Finotto, S ;
De Sanctis, GT ;
Lehr, HA ;
Herz, U ;
Buerke, M ;
Schipp, M ;
Bartsch, B ;
Atreya, R ;
Schmitt, E ;
Galle, PR ;
Renz, H ;
Neurath, MF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1247-1260
[8]   Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma [J].
Foster, PS ;
Ming, Y ;
Matthei, KI ;
Young, IG ;
Temelkovski, J ;
Kumar, RK .
LABORATORY INVESTIGATION, 2000, 80 (05) :655-662
[9]   Signaling molecules as therapeutic targets in allergic diseases [J].
Gorska, MM ;
Alam, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (02) :241-250
[10]   To respond or not to respond: T cells in allergic asthma [J].
Herrick, CA ;
Bottomly, K .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :405-412